Neuronetics Inc (STIM) is around the top of the Diagnostics & Research industry according to InvestorsObserver. STIM received an overall rating of 49, which means that it scores higher than 49 percent of all stocks. Neuronetics Inc also achieved a score of 78 in the Diagnostics & Research industry, putting it above 78 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 105 out of the 148 industries.
STIM has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on STIM!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Neuronetics Inc Stock Today?
Neuronetics Inc (STIM) stock is lower by -3.7% while the S&P 500 is up 0.69% as of 10:26 AM on Tuesday, Aug 29. STIM is lower by -$0.06 from the previous closing price of $1.62 on volume of 61,933 shares. Over the past year the S&P 500 has gained 10.75% while STIM is lower by -59.79%. STIM lost -$1.13 per share the over the last 12 months.
Click Here to get the full Stock Report for Neuronetics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
